Invesco
VYGR icon

Invesco’s Voyager Therapeutics VYGR Stock Holding History

Invesco’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$460K Buy
119,171
+3,171
+3% +$12.5K ﹤0.01% 3197
2025
Q4 		$456K Buy
116,000
+25,522
+28% +$113K ﹤0.01% 3231
2025
Q3 		$423K Buy
90,478
+27,180
+43% +$98.3K ﹤0.01% 3299
2025
Q2 		$197K Buy
63,298
+14,758
+30% +$47.6K ﹤0.01% 3515
2025
Q1 		$164K Buy
48,540
+24,368
+101% +$114K ﹤0.01% 3553
2024
Q4 		$137K Buy
24,172
+1,645
+7% +$10.6K ﹤0.01% 3584
2024
Q3 		$132K Sell
22,527
-109,436
-83% -$796K ﹤0.01% 3582
2024
Q2 		$1.04M Buy
131,963
+110,907
+527% +$930K ﹤0.01% 2902
2024
Q1 		$196K Buy
21,056
+1,852
+10% +$15.6K ﹤0.01% 3653
2023
Q4 		$162K Sell
19,204
-15,403
-45% -$112K ﹤0.01% 3602
2023
Q3 		$268K Sell
34,607
-166,465
-83% -$1.52M ﹤0.01% 3496
2023
Q2 		$2.3M Buy
+201,072
New +$2.08M ﹤0.01% 2582
2020
Q4 		– Sell
-59,944
Closed -$639K – 3828
2020
Q3 		$639K Buy
59,944
+53
+0.1% +$622 ﹤0.01% 3026
2020
Q2 		$756K Sell
59,891
-24,216
-29% -$282K ﹤0.01% 2936
2020
Q1 		$770K Buy
84,107
+4,503
+6% +$51.7K ﹤0.01% 2851
2019
Q4 		$1.11M Sell
79,604
-313,951
-80% -$4.56M ﹤0.01% 2945
2019
Q3 		$6.77M Sell
393,555
-27,600
-7% -$579K ﹤0.01% 1959
2019
Q2 		$11.5M Buy
421,155
+364,516
+644% +$8.34M ﹤0.01% 1690
2019
Q1 		$1.08M Sell
56,639
-40,270
-42% -$525K ﹤0.01% 2983
2018
Q4 		$911K Buy
+96,909
New +$1.24M ﹤0.01% 3026
2018
Q3 		– Sell
-13,269
Closed -$259K – 3928
2018
Q2 		$259K Buy
+13,269
New +$262K ﹤0.01% 3640
2018
Q1 		– Sell
-58,685
Closed -$974K – 3773
2017
Q4 		$974K Buy
+58,685
New +$1.01M ﹤0.01% 3016

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco's VYGR Position: Q1 2026 in Review

Invesco increased its Voyager Therapeutics (VYGR) stake by 2.7% in Q1 2026, buying an estimated $12.5K and bringing the position to 119,171 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #3197.

Invesco first reported a position in VYGR in Q4 2017 and has held it in 22 quarters since. The position peaked at $11.5M in Q2 2019. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Invesco held 119,171 shares of Voyager Therapeutics worth $460K as of Q1 2026.
  • Invesco bought 3,171 Voyager Therapeutics shares in Q1 2026, an estimated $12.5K.
  • Voyager Therapeutics made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3197 holding.
  • Invesco first reported a position in Voyager Therapeutics in Q4 2017 and has held it in 22 quarters since.
  • Invesco's Voyager Therapeutics position peaked at $11.5M in Q2 2019.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.